KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Cash (2016 - 2025)

Historic Change in Cash for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$2.4 million.

  • Biolife Solutions' Change in Cash fell 21639.42% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 884.59%. This contributed to the annual value of $59.9 million for FY2024, which is 27632.14% up from last year.
  • Per Biolife Solutions' latest filing, its Change in Cash stood at -$2.4 million for Q3 2025, which was down 21639.42% from -$35.0 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Change in Cash high stood at $71.2 million for Q4 2024, and its period low was -$35.3 million during Q2 2022.
  • In the last 5 years, Biolife Solutions' Change in Cash had a median value of -$2.4 million in 2025 and averaged -$3.2 million.
  • As far as peak fluctuations go, Biolife Solutions' Change in Cash crashed by 279791.67% in 2021, and later surged by 40794.3% in 2022.
  • Biolife Solutions' Change in Cash (Quarter) stood at -$5.4 million in 2021, then plummeted by 41.34% to -$7.7 million in 2022, then skyrocketed by 310.25% to $16.1 million in 2023, then surged by 341.96% to $71.2 million in 2024, then crashed by 103.4% to -$2.4 million in 2025.
  • Its Change in Cash was -$2.4 million in Q3 2025, compared to -$35.0 million in Q2 2025 and -$28.4 million in Q1 2025.